Norges Bank Checkpoint Therapeutics, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2023
BUY
$1.53 - $3.25 $410,805 - $872,625
268,500 New
268,500 $475,000
Q1 2022

May 09, 2022
SELL
$1.53 - $3.25 $410,805 - $872,625
-268,500 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$2.68 - $4.46 $719,580 - $1.2 Million
268,500 New
268,500 $835,000

Others Institutions Holding CKPT

# of Institutions
3
Shares Held
1.91M
Call Options Held
0
Put Options Held
0
View Full List

About Checkpoint Therapeutics, Inc.

CKPT Quotes by TradingView
  • Ticker CKPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,497,000
  • Market Cap $297M
  • Description
  • Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to...
More about CKPT
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email